心身症状量表在抑郁发作患者中的临床应用研究

Clinical application of Psychosomatic Symptom Scale in patients with depressive episode

目的:使用心身症状量表(PSSS)、9条目患者健康问卷(PHQ-9)、广泛性焦虑障碍量表(GAD-7)及患者健康问卷躯体症状群量表(PHQ-15)同时评估抑郁发作患者,以探讨PSSS评估抑郁、焦虑和心身症状的效能。方法:选取193例抑郁发作患者,分别于入组当天及2周末采用PSSS、PHQ-9、GAD-7及PHQ-15评估抑郁、焦虑及心身症状,将治疗前后各量表因子分及2周减分率进行Pearson相关分析,评价PSSS与其他量表的等效性。结果:治疗前后,PSSS评分与PHQ-9、GAD-7、PHQ-15评分均呈显著正相关(均r>0,P<0.001);PSSS评分减分率与PHQ-9、GAD-7及PHQ-15评分减分率也均呈显著正相关(均r>0,P<0.001);PSSS与PHQ-9、GAD-7、PHQ-15评估抑郁、焦虑及心身症状的治疗有效性(减分率≥50%)相比,差异均无统计学意义(均P>0.05)。结论:PSSS可有效评估抑郁发作患者的抑郁、焦虑和心身症状的严重程度,并可作为疗效的评价工具。

Objective:To use the Psychosomatic Symptoms Scale(PSSS),the 9-item Patient Health Questionnaire(PHQ-9),the Generalized Anxiety Disorder Scale(GAD-7),and the Patient Health Questionnaire Somatic Symptoms Group Scale(PHQ-15)to evaluate patients with depressive episode to explore the efficacy of PSSS in assessing depression,anxiety,and psychosomatic symptoms.Methods:A total of 193 patients with depressive episode were selected.The depressive symptoms,anxiety symptoms and somatic symptom were assessed by PSSS,PHQ-9,GAD-7 and PHQ-15 on the enrollment day and 2 weekends,respectively.Pearson correlation analysis was performed on the score of each scale and 2-week reduction rate before and after treatment to evaluate the equivalence between PSSS and other scales.Results:Before and after treatment,PSSS scores were significantly positively correlated with PHQ-9,GAD-7 and PHQ-15 scores(P<0.001);There was a significant positive correlation between the reduction rate of PSSS scores and PHQ-9,GAD-7 and PHQ-15 scores(P<0.001);Compared with PHQ-9,GAD-7 and PHQ-15 in the evaluation of the efficacy of depression,anxiety and somatic symptoms(reduction rate≥50%),there was no statistical significance in PSSS(P>0.05).Conclusion:The PSSS can be used as a tool to evaluate the severity of depression,anxiety and psychosomatic symptoms in patients with depressive episode.